ArticleHaematologica2017
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.
Abstract readLetter
In one paragraph
Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A meta-analysis of diagnostic challenges in Ph-like ALL at baseline: early detection strategies for personalized therapeutic interventions.International journal of hematology · 2025Pooled it
- Trial
- Identification of Molecular Subtypes of B-Cell Acute Lymphoblastic Leukemia in Mexican Children by Whole-Transcriptome Analysis.International journal of molecular sciences · 2025Article
- Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings.Molecular diagnosis & therapy · 2025Review
- Survival prediction for Philadelphia chromosome-like acute lymphoblastic leukemia by machine learning analysis: a multicenter cohort study.Frontiers in cell and developmental biology · 2025Article
- Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia.Clinical and experimental medicine · 2023Article
- 'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.British journal of cancer · 2023Article
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.British journal of cancer · 2022Article
- Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.International journal of molecular sciences · 2022Review
- Article
- Case Report: Precision Medicine Target Revealed byFrontiers in oncology · 2022Article
- Review
- Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia.Bone marrow transplantation · 2021Article
- Article
- Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.Genes · 2021Review
- Article
- Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan.Scientific reports · 2021Article
- New Approaches to Treating Challenging Subtypes of ALL in AYA Patients.Current hematologic malignancy reports · 2020Review
- [Diagnosis of adult Philadelphia chromosome-like acute lymphoblastic leukemia by fluorescence in situ hybridization].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2020Article
- Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia.British journal of cancer · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Susan L HeatleyCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Teresa SadrasCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Chung H KokCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Eva NievergallCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Kelly QuekCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Phuong DangCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Barbara McClureCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Nicola VennMolecular Diagnostics, Children's Cancer Institute, Sydney, NSW, Australia.
Sarah MooreGenetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
Jeffrey SuttleGenetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
Tamara LawMolecular Diagnostics, Children's Cancer Institute, Sydney, NSW, Australia.
Anthea NgAustralian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
Walter MuskovicMolecular Diagnostics, Children's Cancer Institute, Sydney, NSW, Australia.
Murray D NorrisMolecular Diagnostics, Children's Cancer Institute, Sydney, NSW, Australia.
Tamas ReveszDiscipline of Medicine, University of Adelaide, SA, Australia.
Michael OsbornAustralian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
Andrew S MooreAustralian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
Ram SuppiahMater Children's Hospital Brisbane, QLD, Australia.
Chris FraserAustralian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
Frank AlvaroAustralian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
Timothy P HughesCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Charles G MullighanDepartment of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
Glenn M MarshallAustralian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
Luciano Dalla PozzaAustralian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
David T YeungCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Rosemary SuttonAustralian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
Deborah L WhiteCancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia deborah.white@sahmri.com.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdolescentChildChild, PreschoolHumansInfantPhiladelphia ChromosomePrecision MedicinePrecursor Cell Lymphoblastic Leukemia-LymphomaPrevalenceRecurrenceRisk Assessment
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.